Graphite Bio
Biotechnology
Graphite Bio valuation and funding history | Last updated: March 11, 2021 | 1 funding rounds
Current Valuation
N/A
As of March 11, 2021
Total Funding Raised
N/A
Across 1 round
Last Round
Early Stage VC (Series B)
$150.0M
Last Funding
Mar 2021
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| March 11, 2021 | Early Stage VC (Series B) | $150.0M | N/A | - |
Valuation Analysis
Current Valuation Metrics
Graphite Bio is currently valued at N/A as of March 11, 2021.
What is Graphite Bio Worth in 2026?
Graphite Bio is a leading private company in the Biotechnology sector. Track Graphite Bio's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Graphite Bio Valuation is Determined
Private company valuations like Graphite Bio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.